Publication Details
Abstract
Phosphatidylcholine (PC) is a major hepatocyte phospholipid and a choline-bearing substrate for membrane renewal and lipoprotein assembly. We evaluated a stabilized soybean-lecithin softgel and placed its physicochemical performance beside human evidence on choline and phosphatidylcholine in hepatic physiology. The NVTIA® fill contains 75.00% fluid soybean lecithin, 24.52% caprylic/capric triglyceride, 0.34% mixed tocopherols, and 0.14% L-ascorbyl palmitate. Processing used low-temperature vacuum dehydration, nitrogen-protected mixing, vacuum degassing, and filtration. After 30 days at 40°C/75% relative humidity, the optimized system retained 96.4% PC, with a peroxide value of 3.5 mmol/kg and 0.8% oil leakage. Comparator formulations that removed antioxidant protection, changed the carrier oil, or increased moisture/oxygen exposure showed lower PC retention and/or higher peroxide values. Human feeding studies show that choline availability is necessary for hepatic integrity, and contemporary MASLD trials of essential phospholipids or phosphatidylcholine report changes in steatosis, liver biochemistry, oxidative-stress measures, or related metabolic endpoints. The experimental result is therefore a delivery result: the formulation maintains a defined choline-bearing phospholipid matrix over storage. That platform can be taken forward into pharmacokinetic and liver-focused human studies with verified PC exposure.